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All values are: n (%). No differences were found in the other subgroups.
CONCLUSIONS. The results of this study, which is the first attempt to use L-arginine in
STEMI, showed that long-term oral L-arginine supplementation was well tolerated. Signif-
icant beneficial effects were found in patients with previous MI and also in those with
hyperlipidemia. In this relatively small study group a small positive trend was observed in
all patients, but larger trial is warranted to confirm or refute these promising preliminary
results.
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Background: Risk factors for reinfarction after primary PCI utilizing contemporary tech-
niques, including stents and glycoprotein IIb/IIIa inhibitors, have not been described.
Methods: The clinical and angiographic correlates of reinfarction after primary PCI were
examined from the prospective, multicenter CADILLAC trial, in which 2,082 non shock
patients presenting with AMI within 12 hours of symptom onset were randomized to
PTCA vs. stenting, each + abciximab.
Results: Reinfarction occurred in 17 pts (0.8%) within 30 days, and in 48 pts (2.3%)
within 1 year after PCI. Reinfarction by 1 year occurred in 2.2% of pts after PTCA only,
2.9% after PTCA + abciximab, 2.2% after stenting alone, and 2.2% after stenting + abcix-
imab (P=0.85). Compared to pts without reinfarction, those with reinfarction more often
had hypertension (63% vs. 48%, P=0.06), insulin requiring diabetes (15% vs. 3.6%,
p=0.002), and LAD infarction (54% vs. 36%, p=0.01), but were less likely to be current
smokers (25% vs. 43%, p=0.01). The incidence of multivessel disease was similar in pts
with and without reinfarction. Procedural success (79% vs. 92%, p=0.007) and post-pro-
cedure minimal luminal diameter (2.26mm vs. 2.47mm, p=0.009) were lower in reinfarc-
tion pts, though final TIMI-3 flow rates were similar. By multivariate analysis, insulin
requiring diabetes (HR =7.25, 95% CI [2.5, 21.2], p=0.0003), LAD infarct vessel (HR =
2.7 [1.2, 6.0], p=0.02), and current smoking at baseline (HR = 0.45 [0.19, 1.08], p=0.07)
were independent predictors of reinfarction within 1 year. Specifically, reinfarction at 1-
year occurred in 8.8% of pts with insulin requiring diabetes vs 2.0% without this condition
(P=0.002), and in 3.4% of pts with LAD infarction vs 1.7% with non-LAD infarcts
(P=0.01).
Conclusion: Reinfarction rates after primary PCI of AMI are strikingly increased in
patients with insulin requiring diabetes, and are also greater in patients with anterior inf-
arction. Neither stents nor glycoprotein IIb/IIIa inhibitors reduce the rate of reinfarction
compared to balloon angioplasty. Close surveillance is warranted, and new strategies
deserve study to determine if the rate of reinfarction in these high risk subsets can be
reduced.
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801-1 In Women With Symptoms of Ischemic Heart Disease, 
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Introduction The WISE study was organized to improve diagnostic tests for assigning
risk in women with symptoms of ischemic heart disease (IHD). MRI myocardial perfusion
imaging (MPI) can be quantitatively analyzed to calculate perfusion indices. The perfu-
sion indices can be used to assess the presence of regional ischemia or scar (RIS) or
averaged to generate a global myocardial perfusion index (GMPi).
Hypothesis We hypothesize that global assessment of myocardial perfusion better
assigns risk than assessment of regions of relative hypoperfusion.
Methods Women (n=133), mean age 56±11 (31-85) years, 32% minorities with symp-
toms of IHD underwent MR and single photon positron emission computed tomography
(SPECT) MPI evaluation. Follow-up was conducted over 38±14 months to monitor the
occurrence of myocardial infarction (MI) or all-cause death. Quantitative myocardial per-
fusion analysis was performed on MR data by registering first pass perfusion images,
extracting time intensity curves for the myocardium and normalizing using the left ventric-
ular blood pool signal. Integrating the normalized time intensity curve formed the GMPi.
Comparison of the normalized slopes and intensities between regions was used to detect
RIS. In a blinded manner, the MR and SPECT MPI data were used to categorize patients
as having a RIS; or by MR as having a GMPi in the lower 25th percentile.
Results At follow-up, 10 pts (7%) experienced an MI or death. Kaplan Meier event-free
survival analysis was performed and the log rank statistic calculated between low and
high risk groups for: SPECT RIS 1.99 (p=0.16), MR RIS, 1.03 (p=0.31); low MR GMPi,
6.78 (p < 0.01). Using the MR data, patients categorized as having either a low GMPi or
a RIS had a log rank statistic of 8.49 (p <0.005).
Conclusions
Kaplan Meier event-free survival analysis was used to assess time to cardiac death or MI
(n=10, 7%) and compared using a log rank statistic. A low MR GMPi was associated with
a 6.8-fold increased risk of death or MI (82% event-free survival as compared with 96%
event-free survival for those with a high MR GMPi. The presence of a low GMPi with RIS
data was a significantly better estimator of hard cardiac events than any sole hypoperfu-
sion index, SPECT or MRI.
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Early epicardial (TIMI) and myocardial (MBG) reperfusion are predictors of survival in
patients with AMI. Whether MBG is equality predictive of survival for men and women is
unknown. Methods: 1,301 patients with AMI<12 hours without shock enrolled in the
CADILLAC trial underwent primary PCI. Post procedural MBG was analyzed at an inde-
pendent core lab, and classified as absent (MBG 0/1) or present (MBG 2/3). Results:
Compared to men (n=935), women (n=366) were older (57 vs. 67 yrs, p<0.001), had
more hypertension (43.4 vs. 59.8%, p,0.001), hyperlipidemia (36.5 vs. 45.4%, p=0.004),
diabetes (14.9 vs. 25.4%, p<0.001), less smoking (47.1 vs. 36.1%, p<0.001), and a
greater delay to mechanical reperfusion (3.8 vs.4.9 hrs, p<0.001). Women had lower
MBG 0/1 at baseline (91.2 vs. 86.7% women, p=0.02) and final procedure (50.8 vs.
43.2% women, p=0.02). One year survival curve for men and women are shown in the
tables below. By multivariate analysis, MBG 0/1 was a predictor of death at 1 year for all
women OR 5.15, 95%CI (1.98, 13.4), as well as for women with final TIMI 3 flow, OR
4.63, 95%CI (1.74, 12.3); but was not a predictor in men. Conclusions: Among women
undergoing primary PCI for AMI, the presence of impaired myocardial perfusion despite
normal epicardial perfusion is a strong independent predictor of mortality. 
Placebo Arginine P OR [95%CI]
All patients n=398 n=394
In-hospital CV death 32 (8.0) 28 (7.1) 0.23
CV death up to 6 months 41 (10.3) 35 (8.9) 0.39
In-hospital recurrent ischemia 33 (8.3) 24 (6.1) 0.66
Patients with previous MI n=54 n=51
In-hospital CV death 9 (16.7) 5 (9.8) 0.09
CVdeath up to 6 months 14 (25.9) 5 (9.8) 0.032 0.31[0.21,0.86]
Patients with hyperlipidemia n=113 n=114
In-hospital recurrent ischemia 14 (12.4) 3 (2.6) 0.005 0.19[0.06,0.64]
